C

Curocell

15 employees

Curocell’s OVIS™ technology enhances immune cells to overcome immune suppression in tumor microenvironments.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
CAR-T
T cell
Biopharma
Immune cell therapy

Date founded

2016

Funding rounds raised

Total raised

$35M

from 8 investors over 8 rounds

C

Curocell raised $29M on January 4, 2022

Investors: DS Asset Management and Quadim,LLC

C

Curocell raised $35M on August 10, 2020

Investors: Quadim,LLC, LB Investment, Hana Ventures and IMM Investment Corp.

C

Curocell raised undisclosed on October 1, 2018

Investors: STIC Ventures

C

Curocell raised undisclosed on January 1, 2018

Investors: Company K Partners

FAQ